Top

Diabetologia

Published in:

01-10-2005 | Article

Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study

Authors: H.-F. Lin, B. Boden-Albala, S. H. Juo, N. Park, T. Rundek, R. L. Sacco

Published in: Diabetologia | Issue 10/2005

Abstract

Aims/hypothesis

Growing evidence suggests that the traits comprising the metabolic syndrome have a genetic basis. However, studies of genetic contributions to the syndrome are sparse. Against this background, we sought to estimate the heritability of the metabolic syndrome and its component traits.

Materials and methods

We investigated 803 subjects from 89 Caribbean-Hispanic families who have enrolled to date in the current Northern Manhattan Family Study and for whom metabolic syndrome information was available. Metabolic syndrome was defined in accordance with the National Cholesterol Education Program Adult Treatment Panel III (NCEP/ATPIII) criteria. Variance component methods were used to estimate age and sex-adjusted heritability of the metabolic syndrome and its components. To obtain the structures underlying the metabolic syndrome, we performed principal component factor analyses using six quantitative phenotypes included in the ATPIII definition.

Results

The heritability for the metabolic syndrome was 24% (p=0.009), and ranged from 16 to 60% for its five components. Factor analysis yielded two independent factors (factor 1: lipids/glucose/obesity; factor 2: blood pressure). Heritability analysis revealed significant genetic effects on both factors (44% for lipids/glucose/obesity, and 20% for blood pressure).

Conclusions/interpretation

In the Caribbean-Hispanic families investigated, we demonstrated moderate and significant heritabilities for the metabolic syndrome itself, as well as for individual components and independent factors of the syndrome. These results provide evidence that could support future tasks of mapping susceptibility loci for this syndrome.

(2002) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143–3421

Despres JP, Lamarche B, Mauriege P et al (1996) Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952–957CrossRefPubMed

Lempiainen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J (1999) Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 100:123–128PubMed

Lakka HM, Laaksonen DE, Lakka TA et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716CrossRefPubMed

Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K (2000) Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 20:538–544PubMed

Ninomiya J, L’Italian G, Criqui M, Whyte J (2004) Association of the metabolic syndrome with a history of stroke in the Third National Health and Nutrition Examination Survey. Circulation 109:42–46CrossRefPubMed

Kekalainen P, Sarlund H, Pyorala K, Laakso M (1999) Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes. Diabetes Care 22:86–92PubMed

Hanson RL, Imperatore G, Bennett PH, Knowler WC (2002) Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes 51:3120–3127PubMed

Reilly MP, Rader DJ (2003) The metabolic syndrome: more than the sum of its parts? Circulation 108:1546–1551CrossRefPubMed

10.

Raji A, Seely EW, Arky RA, Simonson DC (2001) Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 86:5366–5371CrossRefPubMed

11.

Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287:356–359CrossRefPubMed

12.

Meigs JB, Wilson PW, Nathan DM, D’Agostino RB Sr, Williams K, Haffner SM (2003) Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 52:2160–2167PubMed

13.

Poulsen P, Vaag A, Kyvik K, Beck-Nielsen H (2001) Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia 44:537–543CrossRefPubMed

14.

Freeman MS, Mansfield MW, Barrett JH, Grant PJ (2002) Heritability of features of the insulin resistance syndrome in a community-based study of healthy families. Diabet Med 19:994–999CrossRefPubMed

15.

Mills GW, Avery PJ, McCarthy MI et al (2004) Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia 47:732–738CrossRefPubMed

16.

Austin MA, Edwards KL, McNeely MJ et al (2004) Heritability of multivariate factors of the metabolic syndrome in nondiabetic Japanese Americans. Diabetes 53:1166–1169PubMed

17.

Stunkard AJ, Harris JR, Pedersen NL, McClearn GE (1990) The body-mass index of twins who have been reared apart. N Engl J Med 322:1483–1487PubMed

18.

Heller DA, de Faire U, Pedersen NL, Dahlen G, McClearn GE (1993) Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 328:1150–1156CrossRefPubMed

19.

Hong Y, de Faire U, Heller DA, McClearn GE, Pedersen N (1994) Genetic and environmental influences on blood pressure in elderly twins. Hypertension 24:663–670PubMed

20.

Hong Y, Pedersen NL, Brismar K, Hall K, de Faire U (1996) Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab 81:1791–1797CrossRefPubMed

21.

Mahaney MC, Blangero J, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW (1995) Plasma HDL cholesterol, triglycerides, and adiposity. A quantitative genetic test of the conjoint trait hypothesis in the San Antonio Family Heart Study. Circulation 92:3240–3248PubMed

22.

Olswold C, de Andrade M (2003) Localization of genes involved in the metabolic syndrome using multivariate linkage analysis. BMC Genet 4(Suppl 1):S57CrossRefPubMed

23.

Edwards KL, Newman B, Mayer E, Selby JV, Krauss RM, Austin MA (1997) Heritability of factors of the insulin resistance syndrome in women twins. Genet Epidemiol 14:241–253CrossRefPubMed

24.

Arya R, Blangero J, Williams K et al (2002) Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes 51:841–847PubMed

25.

Langefeld CD, Wagenknecht LE, Rotter JI et al (2004) Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study. Diabetes 53:1170–1174PubMed

26.

Ng MC, So WY, Lam VK et al (2004) Genome-wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21–q25. Diabetes 53:2676–2683PubMed

27.

Sacco RL, Benson RT, Kargman DE et al (2001) High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA 285:2729–2735CrossRefPubMed

28.

Berglund L, Oliver EH, Fontanez N et al (1999) HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects. Am J Clin Nutr 70:992–1000PubMed

29.

Wahlefeld A, Bergmeyer H (1974) Methods of enzymatic analysis, 2nd edn. Academic, New York, NY

30.

Haffner SM, Stern MP, Hazuda HP, Pugh J, Patterson JK, Malina R (1986) Upper body and centralized adiposity in Mexican Americans and non-Hispanic Whites: relationship to body mass index and other behavioral and demographic variables. Int J Obes 10:493–502PubMed

31.

Stevens J (1986) Applied multivariate statistics for the social sciences. Lawrence Erlbaum Associates, Hills-dale, NJ

32.

Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198–1211CrossRefPubMed

33.

Duggirala R, Williams JT, Williams-Blangero S, Blangero J (1997) A variance component approach to dichotomous trait linkage analysis using a threshold model. Genet Epidemiol 14:987–992CrossRefPubMed

34.

Ferrannini E, Haffner SM, Mitchell BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416–422CrossRefPubMed

35.

Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G (1996) A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities Baseline Study. Diabetes Care 19:414–418PubMed

36.

Schmidt MI, Watson RL, Duncan BB et al (1996) Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study investigators. Metabolism 45:699–706CrossRefPubMed

37.

Beck-Nielsen H (1999) General characteristics of the insulin resistance syndrome: prevalence and heritability. European Group for the Study of Insulin Resistance (EGIR). Drugs 58(Suppl 1):7–10, discussion 75–82

38.

Mitchell BD, Kammerer CM, Mahaney MC et al (1996) Genetic analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vasc Biol 16:281–288PubMed

39.

McQueen MB, Bertram L, Rimm EB, Blacker D, Santangelo SL (2003) A QTL genome scan of the metabolic syndrome and its component traits. BMC Genet 4(Suppl 1):S96CrossRefPubMed

40.

Henkin L, Bergman RN, Bowden DW et al (2003) Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol 13:211–217CrossRefPubMed

41.

Mitchell BD, Kammerer CM, Blangero J et al (1996) Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans: the San Antonio Family Heart Study. Circulation 94:2159–2170PubMed

42.

Freeman MS, Mansfield MW, Barrett JH, Grant PJ (2003) Insulin resistance: an atherothrombotic syndrome. The Leeds Family Study. Thromb Haemost 89:161–168PubMed

43.

Chen W, Srinivasan S, Elkasabany A, Berenson G (1999) Cardiovascular risk factors clustering features of insulin resistance syndrome (syndrome X) in a biracial (Black–White) population of children, adolescents, and young adults: the Bogalusa Heart Study. Am J Epidemiol 150:667–674PubMed

44.

Loos RJ, Katzmarzyk PT, Rao DC et al (2003) Genome-wide linkage scan for the metabolic syndrome in the HERITAGE Family Study. J Clin Endocrinol Metab 88:5935–5943CrossRefPubMed

45.

Meigs J, D’Agostino R, Wilson P, Cupples L, Nathan D, Singer D (1997) Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 46:1594–1600PubMed

46.

Meigs JB (2000) Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 152:908–911CrossRefPubMed

47.

Edwards KL, Burchfiel CM, Sharp DS et al (1998) Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men. Am J Epidemiol 147:441–447PubMed

48.

McBean AM, Li S, Gilbertson DT, Collins AJ (2004) Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: Whites, Blacks, Hispanics, and Asians. Diabetes Care 27:2317–2324PubMed

49.

Haffner S, Taegtmeyer H (2003) Epidemic obesity and the metabolic syndrome. Circulation 108:1541–1545CrossRefPubMed

50.

Boden-Albala B, Giardina EG, Rundek T, Lee H, Sacco RL (2003) Stroke risk and the metabolic syndrome: findings from the Northern Manhattan Study. Neurology 60(Suppl 1):A255–A256CrossRef

Title: Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study
Authors: H.-F. Lin
B. Boden-Albala
S. H. Juo
N. Park
T. Rundek
R. L. Sacco
Publication date: 01-10-2005
Publisher: Springer-Verlag
Published in: Diabetologia / Issue 10/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-005-1892-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study

Abstract

Aims/hypothesis

Materials and methods

Results

Conclusions/interpretation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Aims/hypothesis

Materials and methods

Results

Conclusions/interpretation

Please log in to get access to this content

Other articles of this Issue 10/2005

Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes

Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells

Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor

Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity?

Comment

To: Biason-Lauber A, Boehm B, Lang-Muritano M et al. (2005) Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900–905

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page